TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24265819

Group type: COMPARATOR
Intervention: Standard doses group (20 μg IM at months 0, 1, and 6)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Four doses group (20 μg IM at months 0, 1, 2, 6)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Four double doses group (40 μg IM at months 0, 1, 2, 6)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Four double doses group
Number of subjects: 132
Study: 21943318

Group type: EXPERIMENTAL
Intervention: Movement control exercise
Number of subjects: 106

Group type: COMPARATOR
Intervention: General exercise
Number of subjects: 106
Study: 18316660

Group type: EXPERIMENTAL
Intervention: After-school soccer program
Number of subjects: 21

Group type: COMPARATOR
Intervention: After-school health education program
Number of subjects: 21
Study: 17136943

Group type: EXPERIMENTAL
Intervention: Carbohydrate plus protein drink (6% CHO, 1.5% protein)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Carbohydrate-only drink (6% CHO)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Water (WA)
Number of subjects: 13
Study: 12752347

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Omeprazole 20 mg
Number of subjects: 27
Study: 10877734

Group type: EXPERIMENTAL
Intervention: Single doses of rofecoxib, 250 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Single doses of indomethacin, 75 mg
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multiple doses of rofecoxib, 12.5 mg/d
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multiple doses of rofecoxib, 25 mg/d
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Multiple doses of indomethacin, 50 mg three times daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 9106016

Group type: EXPERIMENTAL
Intervention: Azithromycin 3-day course (10 mg/kg daily)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Azithromycin 5-day course (10 mg/kg on day 1 and 5 mg/kg on days 2‐5)
Number of subjects: 371
Study: 8197429

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 100
Study: 3492153

Group type: EXPERIMENTAL
Intervention: Nimodipine (0.09 mg/kg X h)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control (0.9% saline solution)
Number of subjects: 52
Study: 30413328

Group type: EXPERIMENTAL
Intervention: Public support for policy strategies targeting schools, marketing, and the built environment.
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: Perceptions of factors contributing to childhood obesity.
Number of subjects: 2066

Group type: EXPERIMENTAL
Intervention: Attribution of responsibility for childhood obesity.
Number of subjects: 2066
Study: 28560802

Group type: EXPERIMENTAL
Intervention: 40 mg prednisolone
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 27103409

Group type: COMPARATOR
Intervention: Enhanced care (screening recommendation and FOBT kit mailed annually)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Education (health literacy appropriate pamphlet and simplified FOBT instructions)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Nurse support (same as education but with nurse follow-up)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 206
Study: 24702700

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 455

Group type: COMPARATOR
Intervention: Insulin detemir (IDet)
Number of subjects: 455
Study: 21441205

Group type: EXPERIMENTAL
Intervention: Ecologically based weight gain prevention interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention adoption by sites
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy eating interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Institutional level maintenance of interventions
Number of subjects: 0
Study: 20981001

Group type: EXPERIMENTAL
Intervention: Endoxifen, single oral doses ranging from 0.5 to 4.0 mg
Number of subjects: 0
Study: 18843429

Group type: EXPERIMENTAL
Intervention: Cervical spine mobilization
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (socializing visits)
Number of subjects: 15
Study: 15701465

Group type: EXPERIMENTAL
Intervention: 8 weeks of exercise training (5 days/week, submaximal bicycle ergometer training, 30 min/day; calisthenics 9 min/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: 8 weeks of rest
Number of subjects: 18
Study: 11850257

Group type: EXPERIMENTAL
Intervention: 600 mg of amprenavir with 100 mg of ritonavir twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Once-daily regimens
Number of subjects: 0
Study: 10188720

Group type: EXPERIMENTAL
Intervention: TIL from tumor biopsies
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: IL-2-stimulated TIL cell lines
Number of subjects: 9
Study: 7757892

Group type: EXPERIMENTAL
Intervention: Newsletter recipients (experimental group)
Number of subjects: 453

Group type: COMPARATOR
Intervention: Nonrecipients (control group)
Number of subjects: 453
Study: 2334625

Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 30
Study: 84259

Group type: EXPERIMENTAL
Intervention: Alternate-day prednisone (35 mg/m2/48 h)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intermittent prednisone (40 mg/m2 on three consecutive days out of seven)
Number of subjects: 23
Study: 31107694

Group type: EXPERIMENTAL
Intervention: Aerobic and Resistance Training (ART) for 12 weeks
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine Training (TCMT) for 12 weeks
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 141
Study: 28285001

Group type: EXPERIMENTAL
Intervention: Footwear for self-management
Number of subjects: 91
Study: 25827607

Group type: EXPERIMENTAL
Intervention: Advanced rider training course 'Risk' (n=137)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (n=85)
Number of subjects: 222
Study: 23519654

Group type: EXPERIMENTAL
Intervention: 4-week self-management intervention (n=68)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care (n=78)
Number of subjects: 147
Study: 20869706

Group type: EXPERIMENTAL
Intervention: GnRH agonists combined with GnRH antagonists
Number of subjects: 0

Group type: COMPARATOR
Intervention: GnRH agonists alone
Number of subjects: 0
Study: 19560257

Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 2000 mg/100 ml of saline
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo (PBO) 100 ml of saline
Number of subjects: 328
Study: 17126613

Group type: EXPERIMENTAL
Intervention: Health insurance scheme benefits uptake strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Socioeconomic status index
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rank score interpolation
Number of subjects: 0
Study: 15001970

Group type: EXPERIMENTAL
Intervention: St John's wort (300 mg tablet, 3 times daily for 14 days)
Number of subjects: 12
Study: 11771044

Group type: EXPERIMENTAL
Intervention: 10% aqueous sodium bicarbonate
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: 2.5% aqueous acetic acid
Number of subjects: 69
Study: 9225180

Group type: EXPERIMENTAL
Intervention: OKN testing (slow and fast clockwise and counterclockwise)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: OKN testing (slow movements)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: OKN testing (fast movements)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: OKN testing (saccades)
Number of subjects: 70
Study: 8281588

Group type: EXPERIMENTAL
Intervention: 25G Whitacre needle
Number of subjects: 304

Group type: COMPARATOR
Intervention: 24G Sprotte needle
Number of subjects: 304
Study: 3544754

Group type: EXPERIMENTAL
Intervention: 5 mg nisoldipine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 20 mg nisoldipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: 20 mg nifedipine
Number of subjects: 10
Study: 2702166

Group type: EXPERIMENTAL
Intervention: Gracey curette 5/6
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Ultrasound unit
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Air scalers with five different tips
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Sharp-edged instruments
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Automatic calculus removal instruments
Number of subjects: 140
Study: 31176375

Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy (HFOT) during high-intensity exercise training
Number of subjects: 156

Group type: COMPARATOR
Intervention: Standard oxygen delivery via Venturi Mask (V-mask) during high-intensity exercise training
Number of subjects: 156
Study: 28651483

Group type: EXPERIMENTAL
Intervention: Positive information about the energy drink (augments running performance)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Partial-positive information about the energy drink (may or may not improve performance)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neutral information (control group) about the energy drink (could not demonstrate improvement)
Number of subjects: 60
Study: 26517265

Group type: EXPERIMENTAL
Intervention: Mujer Segura intervention
Number of subjects: 77
Study: 23109095

Group type: EXPERIMENTAL
Intervention: ACI and additional HTO (Group A, n = 19)
Number of subjects: 43

Group type: COMPARATOR
Intervention: ACI only (Group B, n = 24)
Number of subjects: 43
Study: 21796026

Group type: EXPERIMENTAL
Intervention: Sitting without back support position (SB) intervention
Number of subjects: 3
Study: 19364680

Group type: EXPERIMENTAL
Intervention: Video (n = 40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Text (n = 40)
Number of subjects: 80
Study: 16759446

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15527158

Group type: EXPERIMENTAL
Intervention: Community-based directly observed treatment (DOT) using guardians and former TB patients
Number of subjects: 587

Group type: COMPARATOR
Intervention: Health facility-based directly observed treatment (DOT)
Number of subjects: 587
Study: 11156732

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 45
Study: 9065189

Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control (no episiotomy)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Shorter second stage of labor
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Unemployment
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Forceps use and birth weight
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Antepartum pelvic floor strength
Number of subjects: 459
Study: 8267425

Group type: EXPERIMENTAL
Intervention: EC + BN 52021 (10 mg/kg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: EC (40 mL/kg)
Number of subjects: 28
Study: 3534041

Group type: EXPERIMENTAL
Intervention: Stress management techniques (six classes including autogenics, personal planning skills, and communication techniques)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study: 30871934

Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 10 mcg/day
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 20 mcg/day
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 40 mcg/day
Number of subjects: 189
Study: 27887033

Group type: EXPERIMENTAL
Intervention: 1% diclofenac + 3% menthol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Menthol gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive control (0.2% sodium lauryl sulfate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference treatments (0.9% saline and marketed gel 1% diclofenac, Voltaren)
Number of subjects: 0
Study: 25683796

Group type: EXPERIMENTAL
Intervention: Exercise (cycling for one hour at 50% of maximum oxygen uptake)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (three hours of rest)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Exercise (for inactive participants)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Active participants
Number of subjects: 20
Study: 23740384

Group type: EXPERIMENTAL
Intervention: 30 ml LZD suspension
Number of subjects: 28

Group type: COMPARATOR
Intervention: 600 mg LZD tablet
Number of subjects: 28
Study: 21940789

Group type: EXPERIMENTAL
Intervention: IFN‐γ1b
Number of subjects: 1156
Study: 18192318

Group type: EXPERIMENTAL
Intervention: Vibrating bladder stimulator
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 97
Study: 17162142

Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.58 g/kg/d)
Number of subjects: 585

Group type: COMPARATOR
Intervention: Usual-protein diet (1.3 g/kg/d)
Number of subjects: 585
Study: 14572566

Group type: EXPERIMENTAL
Intervention: 2 L sulfate‐free electrolyte lavage solution (SF‐ELS) plus 20 mg p.o. bisacodyl
Number of subjects: 200

Group type: COMPARATOR
Intervention: 4 L sulfate-free electrolyte lavage solution (SF‐ELS)
Number of subjects: 200
Study: 10050112

Group type: EXPERIMENTAL
Intervention: Cast posts and cores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Prefabricated, comparably sized, parallel-sided posts with composite cores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Woven fiber post-core system
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Polyethylene woven fiber and composite resin without a prefabricated post
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Smaller diameter prefabricated posts combined with polyethylene woven fiber and composite cores
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Traditional cast posts and cores
Number of subjects: 60
Study: 8678252

Group type: EXPERIMENTAL
Intervention: Semi-rigid cervical collar
Number of subjects: 38

Group type: COMPARATOR
Intervention: Changing support of the airway
Number of subjects: 38
Study: 2202247

Group type: EXPERIMENTAL
Intervention: Furosemide 30 mg
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 6265966

Group type: EXPERIMENTAL
Intervention: Epidemiologic Catchment Area Program (ECA Program)
Number of subjects: 0
Study: 30427880

Group type: EXPERIMENTAL
Intervention: 5-minute warning system using machine learning algorithms (random forests and support vector machines)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: 10-second warning system using machine learning algorithms (random forests and support vector machines)
Number of subjects: 788
Study: 27558396

Group type: EXPERIMENTAL
Intervention: High trans-fatty acids beverage
Number of subjects: 11

Group type: COMPARATOR
Intervention: High saturated fatty acids beverage
Number of subjects: 11
Study: 25468506

Group type: EXPERIMENTAL
Intervention: REAP-HD programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Staff Education (SSE)
Number of subjects: 0
Study: 22267336

Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (including folate, zinc, and vitamins A, B, C, and D)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 58
Study: 20018483

Group type: EXPERIMENTAL
Intervention: Probiotic supplemented formula (Lactobacillus salivarius CECT5713, 2 × 10(6) cfu/g)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (no probiotics)
Number of subjects: 80
Study: 18806036

Group type: EXPERIMENTAL
Intervention: Guided technique
Number of subjects: 99

Group type: COMPARATOR
Intervention: Digital technique
Number of subjects: 99

Group type: COMPARATOR
Intervention: Introducer tool (IT) technique
Number of subjects: 99
Study: 15941684

Group type: EXPERIMENTAL
Intervention: Glucan treatment for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 24
Study: 11813228

Group type: EXPERIMENTAL
Intervention: Latent class mixed models applied to longitudinal data on prostate specific antigen (PSA) and incidence of prostate cancer.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Latent class mixed models for survival endpoint analysis of prostate cancer.
Number of subjects: 0
Study: 9690721

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.d.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Omeprazole 20 mg o.d.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg o.d.
Number of subjects: 16
Study: 7806479

Group type: EXPERIMENTAL
Intervention: Wide-band chirp signals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Frequency-limited chirps
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chirp stimuli
Number of subjects: 0
Study: 2764288

Group type: EXPERIMENTAL
Intervention: Active airway humidification using an airway heater and humidifier set at 37 degrees C (N = 8)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Passive airway humidification using a heat and moisture exchanger (N = 6)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No airway humidification and/or heating (control, N = 6)
Number of subjects: 20
Study: 789219

Group type: EXPERIMENTAL
Intervention: Frubienzym (throat lozenges with 5 mg lysozyme, 2 mg papaine and 200 I.U. bacitracin)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 31074115

Group type: EXPERIMENTAL
Intervention: Incident VTE in SCD patients
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: More severe SCD
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: Lower extremity DVT as the incident event
Number of subjects: 877

Group type: EXPERIMENTAL
Intervention: Pneumonia/acute chest syndrome
Number of subjects: 877
Study: 25997633

Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (small-group session and e-learning)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Standard approach (control group)
Number of subjects: 1600
Study: 23801589

Group type: EXPERIMENTAL
Intervention: CALM treatment
Number of subjects: 1004
Study: 21777477

Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise program (12 weeks, resistance exercises with exercise bands, 1 supervised session/week, at least 2 non-supervised sessions/week)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care (including psychotherapy, pharmaceutical interventions, and group therapy)
Number of subjects: 80
Study: 19623867

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (30-50 mg/kg bolus followed by 500 mg/h continuous infusion)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Isotonic solution (control group)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 68
Study: 17101743

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Varenicline 2 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Varenicline 3 mg daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Varenicline 2 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15603006

Group type: EXPERIMENTAL
Intervention: 10-session vocational problem solving intervention (N=62)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Time and attention control condition (N=47)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Overall sample (both groups)
Number of subjects: 109
Study: 11498066

Group type: EXPERIMENTAL
Intervention: Oral crystalline cyanocobalamin (3000 microg or 5000 microg once a week for at least 3 months)
Number of subjects: 10
Study: 9405901

Group type: EXPERIMENTAL
Intervention: Insulin lispro
Number of subjects: 199
Study: 7635783

Group type: EXPERIMENTAL
Intervention: HDR-6 (6 fractions of 7 Gy per fraction)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: HDR-4 (4 fractions of 8 Gy per fraction)
Number of subjects: 92

Group type: COMPARATOR
Intervention: LDR (40 Gy in two split courses)
Number of subjects: 92
Study: 2705632

Group type: EXPERIMENTAL
Intervention: 3-glucosaminoglycan sulfate
Number of subjects: 30
Study: 325301

Group type: EXPERIMENTAL
Intervention: Guancydine (21 mg/kg body weight for 7 to 18 days)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (during a control period averaging 14 days)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Guancydine
Number of subjects: 9
Study: 31414865

Group type: EXPERIMENTAL
Intervention: CBT plus parental involvement (CBT-PI)
Number of subjects: 136

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 136

Group type: COMPARATOR
Intervention: Social activity
Number of subjects: 136
Study: 31339919

Group type: EXPERIMENTAL
Intervention: Enhanced peer education and routine screening for family planning needs plus expanded non-condom FP method availability in drop-in centers (DIC).
Number of subjects: 719

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention details provided).
Number of subjects: 719
Study: 28056936

Group type: EXPERIMENTAL
Intervention: choline-stabilized orthosilicic acid (ch-OSA)
Number of subjects: 211

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 211
Study: 24796764

Group type: EXPERIMENTAL
Intervention: CC/IUI (Clomiphene Citrate/Intrauterine Insemination)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: FSH/IUI (Follicle Stimulating Hormone/Intrauterine Insemination)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Immediate IVF (In Vitro Fertilization)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 154

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 154
Study: 22429881

Group type: EXPERIMENTAL
Intervention: Restrained eaters
Number of subjects: 111

Group type: COMPARATOR
Intervention: Unrestrained eaters
Number of subjects: 111
Study: 20164585

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 927
Study: 24692821

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19